Octamethylcyclotetrasiloxane exhibits estrogenic activity in mice via ERα

Toxicology and Applied Pharmacology

Volumn 192, Issue 3, 2003, Pages 254-261

  He, Bin ^a,f   Rhodes Brower, Stacey ^b   Miller, Michael R ^b   Munson, Albert E ^c   Germolec, Dori R ^d   Walker, Vickie R ^d   Korach, Kenneth S ^d   Meade, B Jean ^a,e  

^a NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

^b WEST VIRGINIA UNIVERSITY   (United States)

^c Health Effects Laboratory Division   (United States)

^d NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^e MS 4020 ^*  (United States)

^f TherImmune Research Corporation   (United States)

Author keywords

ERKO; Estrogen receptors; Estrogenic activity; ICI 182,780; Octamethylcyclotetrasiloxane; Uterotrophic assays

Indexed keywords

CORTICOSTERONE; DECAMETHYLCYCLOPENTASILOXANE; DECAMETHYLTETRASILOXANE; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; FULVESTRANT; HEXAMETHYLCYCLOTRISILOXANE; OCTAMETHYLCYCLOTETRASILOXANE; OCTAPHENYLCYCLOTETRASILOXANE; PEROXIDASE; SILICONE DERIVATIVE; SILOXANE; UNCLASSIFIED DRUG;

ADRENALECTOMY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; ENZYME ACTIVITY; ESTRADIOL BLOOD LEVEL; ESTROGEN ACTIVITY; FEMALE; MOUSE; NONHUMAN; OVARIECTOMY; RECEPTOR BINDING; UTERUS WEIGHT;

ANIMALIA;

EID: 0142157580     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-008X(03)00282-5     Document Type: Article

References (33)

1. Andersen M.E., Sarangapani R., Reitz R.H., Gallavan R.H., Debrev I.D., Plotzke K.P. Physiological modeling reveals novel pharmacokinetic behavior for inhaled octamethylcyclotetrasiloxane in rats. Toxicol. Sci. 60:2001;214-231.
2. Briggs M., Brotherton J. Steroid Biochemistry and Pharmacology. 1970;Academic Press, London and New York.
3. Bunone G., Briand P.A., Miksicek R.J., Picard D. Activation of the unliganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation. EMBO J. 15:1996;2174-2183.
4. Burns-Naas L.A., Meeks R.G., Kolesar G.B., Mast R.W., Elwell M.R., Hardisty J.F., Thevenaz P. Inhalation toxicology of octamethylcyclotetrasiloxane (D4) following a 3-month nose-only exposure in Fischer 344 rats. Int. J. Toxicol. 21:2002;39-53.
5. Cooke P.S., Buchanan D.L., Young P., Setiawan T., Brody J., Korach K.S., Taylor J., Lubahn D.B., Cunha G.R. Stromal estrogen receptors mediate mitogenic effects of estradiol on uterine epithelium. Proc. Natl. Acad. Sci. USA. 94:1997;6535-6540.
6. Couse J.F., Korach K.S. Estrogen receptor null mice what have we learned and where will they lead us . Endocr. Rev. 20:1999;358-417.
7. Dalu A., Gallavan R.H., Meeker L.S., Quinn A.L., Jean P.A., Crissman J.W., Meeks B.G., Plotzke K.P. Effects of octamethylcyclotetrasiloxane (D4) and phenobarbital (PB) on LH surge and ovulation in Sprague-Dawley (SD) rats. Toxicologist. 66:(1S):2002;343-344.
8. Enan E., Matsumura F. Activation of c-Neu tyrosine kinase by o,p′-DDT and beta-HCH in cell-free and intact cell preparations from MCF-7 human breast cancer cells. J. Biochem. Mol. Toxicol. 12:1998;83-92.
9. Enmark E., Pelto-Huikko M., Grandien K.A.J., Lagercrantz S., Lagercrantz J., Fried G., Nordenskjold M., Gustafsson J.-A. Human estrogen receptor β-gene structure, chromosomal localization, and expression pattern. J. Clin. Endocrinol. Metab. 82:1997;4258-4265.
10. Hafner F., Holler E., vonAngerer E. Effect of growth factors on estrogen receptor mediated gene expression. J. Steroid Biochem. Mol. Biol. 58:1996;385-393.
11. Howell A., Osborne C.K., Morris C., Wakeling A.E. ICI 182,780 (Faslodex) development of a novel, "pure" antiestrogen . Cancer. 89:2000;817-825.
12. Kato S., Endoh H., Masuhiro Y., Kitamoto T., Uchiyama S., Sasaki H., Musushige S., Gotoh Y., Nishida E., Kawashima H., Metzger D., Chambon P. Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase. Science. 270:1995;1491-1494.
13. Korach K.S. Estrogen receptor knock-out mice molecular and endocrine phenotypes . J. Soc. Gynecol. Invest. 7:(S):2000;16-17.
14. Kuiper G.G., Carlsson B., Grandien K., Enmark E., Haggblad J., Nilsson S., Gustafsson J.A. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology. 138:1997;863-870.
15. Le U.T. Mechanisms of humoral immune modulations in B6C3F1 mice following exposure to octamethylcyclotetrasiloxane (D4) [dissertation]. 1997;Department of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, VA.
16. LeVier D.G., Musgrove D.L., Munson A.E. The effect of octamethylcyclotetrasiloxane (D4) on the humoral immune responses in B6C3F1 mice. The Toxicologist. 15:1995;223.
17. Lyttle C.R., DeSombre E.R. Uterine peroxidase as a marker for estrogen action. Proc. Natl. Acad. Sci. USA. 74:1977;3162-3166.
18. Mast R.W., Holson J.F., Stump D.G., Nemec M.D., Reynolds V.L. Inhalation reproductive toxicity study of octamethylcyclotetrasiloxane (D4) in female rats. The Toxicologist. 36:1997;357.
19. McKim J.M. Jr., Choudhuri S., Wilga P.C., Madan A., Burns-Naas L.A., Gallavan R.H., Mast R.W., Naas D.J., Parkinson A., Meeks R.G. Induction of hepatic xenobiotic metabolizing enzymes in female Fischer-344 rats following repeated inhalation exposure to decamethylcyclopentasiloxane (D5). Toxicol. Sci. 50:1999;10-19.
20. McKim J.M. Jr., Wilga P.C., Breslin W.J., Plotzke K.P., Gallavan R.H., Meeks R.G. Potential estrogenic and antiestrogenic activity of the cyclic siloxane octamethylcyclotetrasiloxane (D4) and the linear siloxane hexamethyldisiloxane (HMDS) in immature rats using the uterotrophic assay. Toxicol. Sci. 63:2001;37-46.
21. McKim J.M. Jr., Wilga P.C., Kolesar G.B., Choudhuri S., Madan A., Dochterman L.W., Breen J.G., Parkinson A., Mast R.W., Meeks R.G. Evaluation of octamethylcyclotetrasiloxane (D4) as an inducer of rat hepatic microsomal cytochrome P450, UDP-glucuronosyltransferase, and epoxide hydrolase a 28-day inhalation study . Toxicol. Sci. 41:1998;29-41.
22. Meeks R.G., Thevenaz P., Mast R.W. 1-Month repeated dose inhalation toxicity study with octamethylcyclotetrasiloxane in rats. The Toxicologist. 15:1995;182.
23. Orimo A., Inoue S., Minowa O., Tominaga N., Tomioka Y., Sato M., Kuno J., Hiroi H., Shimizu Y., Suzuki M., Noda T., Muramatsu M. Underdeveloped uterus and reduced estrogen responsiveness in mice with disruption of the estrogen-responsive finger protein gene, which is a direct target of estrogen receptor alpha. Proc. Natl. Acad. Sci. USA. 96:1999;12027-12032.
24. Paech K., Webb P., Kuiper G.G., Nilsson S., Gustafsson J., Kushner P.J., Scanlan T.S. Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites. Science. 277:1997;1508-1510.
25. Plotzke K.P., Crofoot S., Ferdinandi E., Beattie J., Reitz R., McNett D., Meeks R. Disposition of radioactivity in Fischer 344 rats after single and multiple inhalation exposure to [(14)C] octamethylcyclotetrasiloxane ([140C]D94)). Drug Metab. Dispos. 28:2000;192-204.
26. Rabin D., Johnson E., Brandon D., Liapi C., Chrousos G. Glucocorticoids inhibit estradiol-mediated uterine growth possible role of the uterine estradiol receptor . Biol. Reprod. 42:1990;74-80.
27. Sarangapani R., Teeguarden J., Andersen M.E., Reitz R.H., Plotzke K.P. Route-specific differences in distribution characteristics of octamethylcyclotetrasiloxane in rats analysis using PBPK models . Toxicol. Sci. 71:2003;41-52.
28. Stump D.G., Holson J.F., Kirkpatrick D.T., Reynolds V.L., Siddiqui W.H., Meeks R.G. Evaluation of octamethylcyclotetrasiloxane (D4) in a 2-generation reproductive toxicity study in rats. The Toxicologist. 54:2000;370.
29. Wade C.B., Robinson S., Shapiro R.A., Dorsa D.M. Estrogen receptor (ER)alpha and ERbeta exhibit unique pharmacologic properties when coupled to activation of the mitogen-activated protein kinase pathway. Endocrinology. 142:2001;2336-2342.
30. Wade G.N., Blaustein J.D., Gray J.M., Meredith J.M. ICI 182,780 a pure antiestrogen that affects behaviors and energy balance in rats without acting in the brain . Am. J. Physiol. 265:1993;R1392-R1398.
31. Wakeling A.E., Dukes M., Bowler J. A potent specific pure antiestrogen with clinical potential. Cancer Res. 51:1991;3867-3873.
32. Wilson S.D. Modulation of immune and neuroendocrine function by siloxanes [dissertation]. 1996;Department of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, VA.
33. Zhang J., Falany J.L., Xie X., Falany C.N. Induction of rat hepatic drug metabolizing enzymes by dimethylcyclosiloxanes. Chem. Biol. Interact. 124:2000;133-147.